Thus, these results implied that ESM1 KO inhibited PI3K-Akt-mTOR activation, downregulated EMT-promoting proteins, and activated apoptosis in cervical cancer xenografts in vivo. The gene discussed is MTOR; the disease is cervical carcinoma.